EN HU
logo Tudóstér

Szentandrássy Norbert

Szentandrássy Norbert
University of Debrecen Faculty of Medicine
Department of Physiology
2011-
University of Debrecen Faculty of Medicine
Department of Physiology
2003-
University of Debrecen Faculty of Dentistry
Department of Physiology and Pharmacology Dentistry

Publication list

Tudóstér co-authors statistics filterable publication list
Uploaded publications:
132
Publications in DEA:
132
OA:
54
Date range:
2001-2026
2026
1.
Óvári, J., Kovács, Z. M., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Varga, Z., Szentandrássy, N.: Amsacrine modifies action potential configuration without its prolongation via the blockade of multiple ion currents in canine ventricular cells.
Biomed. Pharmacother. 202, 1-14, (article identifier: 119825), 2026.
doi DEA Scopus
Journal metrics:
D1 Medicine (miscellaneous) (2025)
D1 Pharmacology (2025)
2.
Domingos, G. J., Fehér, Á., Teshome, R. T., Husain, S., Papp, F., Amna, A. O., Bangera, K. C., Vizi, Z., Elian, R., Kovács, Z. M., Szentandrássy, N., Piga, M., Tomasic, T., Zidar, N., Varga, Z.: A small molecule voltage-sensor modulator enhances the function of the cardiac NaV1.5 channel.
Biomed. Pharmacother. 200, 1-14, (article identifier: 119530), 2026.
doi DEA
Journal metrics:
D1 Medicine (miscellaneous) (2025)
D1 Pharmacology (2025)
3.
Sárkány, F., Priksz, D., Juhász, B., Fazekas, L., Németh, N., Szentandrássy, N., Horváth, B., Kovács, Z. M., Borbély, A., Ráduly, A. P., Tóth, A., Fagyas, M., Bódi, B., Papp, Z.: Myofilament-level effects of aficamten increase diastolic chamber volumes and maintain cardiac output through preserved length-dependent force generation in healthy rat and canine myocardium.
Basic Res Cardiol. [Epub ahead of print], 2026.
doi DEA WoS Scopus
Journal metrics:
D1 Cardiology and Cardiovascular Medicine (2025)
D1 Physiology (medical) (2025)
D1 Physiology (2025)
4.
Kovács, Z. M., Óvári, J., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Balogh, G., Szentandrássy, N.: The Methanesulfonamide Group: Bright and Dark Sides of hERG Potassium Channel Inhibition.
Pharmaceuticals. 19 (6), 1-19, (article identifier: 882), 2026.
doi DEA WoS Scopus
Journal metrics:
Q1 Drug Discovery (2025)
Q2 Molecular Medicine (2025)
Q1 Pharmaceutical Science (2025)
2025
5.
Óvári, J., Kovács, Z. M., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Szentandrássy, N.: Concentration-dependent electrophysiological effects of amsacrine on canine ventricular cardiomyocytes.
Cor Vasa. 67 (Suppl.), 62, 2025.
DEA
6.
Szentandrássy, N., Óvári, J., Kovács, Z. M., Horváth, B., Magyar, J., Bányász, T., Nánási, P. P.: Conclusions from 20 years of cellular ap recordings: ap parameter correlations, solution-, age-, and sex-dependence.
Cor Vasa. 67 (Suppl.), 74-75, 2025.
DEA
7.
Óvári, J., Kovács, Z. M., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Domingos, G. J., Fehér, Á., Varga, Z., Szentandrássy, N.: Delavirdine modifies action potential configuration via inhibition of IKr and Ito in canine ventricular myocytes.
Biomed. Pharmacother. 186, 1-13, (article identifier: 117994), 2025.
doi DEA Scopus
Journal metrics:
D1 Medicine (miscellaneous)
D1 Pharmacology
8.
Horváth, B., Kovács, Z. M., Dienes, C., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Nánási, P. P.: The slow delayed rectifier K+ current is differently regulated under baseline conditions and following β-adrenergic stimulation in canine ventricular cardiomyocytes.
Sci Rep. 15 (1), 1-11, (article identifier: 41939), 2025.
doi DEA WoS Scopus
Journal metrics:
Q1 Multidisciplinary
2024
9.
Kovács, Z. M., Horváth, B., Dienes, C., Óvári, J., Kiss, D. Z., Hézső, T., Szentandrássy, N., Magyar, J., Bányász, T., Nánási, P. P.: Beta-Adrenergic Activation of the Inward Rectifier K+ Current Is Mediated by the CaMKII Pathway in Canine Ventricular Cardiomyocytes.
Int. J. Mol. Sci. 25 (21), 1-14, (article identifier: 11609), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
10.
Kovács, Z. M., Óvári, J., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Fehér, Á., Varga, Z., Szentandrássy, N.: Correction: Kovács et al. ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr. Pharmaceuticals 2023, 16, 488.
Pharmaceuticals. 17 (9), 1-2, (article identifier: 1137), 2024.
doi DEA WoS Scopus
11.
Horváth, B., Kovács, Z. M., Dienes, C., Barta, Z., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Nánási, P. P.: Relationship between ion currents and membrane capacitance in canine ventricular myocytes.
Sci. Rep. 14 (1), 11241, (article identifier: 11241), 2024.
doi DEA Scopus
Journal metrics:
Q1 Multidisciplinary
2023
12.
Kovács, Z. M., Óvári, J., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Fehér, Á., Varga, Z., Szentandrássy, N.: ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr.
Pharmaceuticals (Basel). 16 (4), 488, (article identifier: 488), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
13.
Ráduly, A. P., Sárkány, F., Kovács, M. B., Juhász, B., Horváth, B., Szentandrássy, N., Nánási, P. P., Édes, I., Csanádi, Z., Tóth, A., Papp, Z., Priksz, D., Borbély, A.: A kardiális miozinaktivátorok klinikai alkalmazhatósága a preklinikai vizsgálatok tükrében.
Cardiol. Hung. 53 (5), 476-483, 2023.
doi DEA Scopus
14.
Horváth, B., Kovács, Z. M., Dienes, C., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Varró, A., Nánási, P. P.: Conductance Changes of Na+ Channels during the Late Na+ Current Flowing under Action Potential Voltage Clamp Conditions in Canine, Rabbit, and Guinea Pig Ventricular Myocytes.
Pharmaceuticals (Basel). 16 (4), 560, (article identifier: 560), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
15.
Ráduly, A. P., Tóth, A., Sárkány, F., Horváth, B., Szentandrássy, N., Nánási, P. P., Csanádi, Z., Édes, I., Papp, Z., Borbély, A.: Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels.
ESC Heart Failure. 10 (2), 1326-1335, 2023.
doi DEA WoS Scopus
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
16.
Naveed, M., Mohammed, A. S. A., Topal, L., Kovács, Z. M., Dienes, C., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Prorok, J., Jost, N., Virág, L., Baczkó, I., Varró, A., Nánási, P. P., Horváth, B.: Selective Inhibition of Cardiac Late Na+ Current Is Based on Fast Offset Kinetics of the Inhibitor.
Biomedicines. 11 (9), 2383, (article identifier: 2383), 2023.
doi DEA WoS Scopus
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
17.
Ráduly, A. P., Sárkány, F., Kovács, M. B., Bernát, B., Juhász, B., Szilvássy, Z., Pórszász, R., Horváth, B., Szentandrássy, N., Nánási, P. P., Csanádi, Z., Édes, I., Tóth, A., Papp, Z., Priksz, D., Borbély, A.: The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications.
Int. J. Mol. Sci. 24 (1), 446, (article identifier: 446), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
18.
Dienes, C., Kovács, Z. M., Óvári, J., Szentandrássy, N.: TRPM4-ioncsatornák vizsgálatának farmakológiai lehetőségei = Pharmacological possibilities of testing TRPM4 ion channels.
Cardiol. Hung. 53 (5), 446-450, 2023.
doi DEA Scopus
2022
19.
Gönczi, M., Csemer, A., Szabó, L., Sztretye, M., Fodor, J., Pocsai, K., Szenthe, K., Keller-Pintér, A., Köhler, Z. M., Nánási, P. P., Szentandrássy, N., Pál, B., Csernoch, L.: Astaxanthin Exerts Anabolic Effects via Pleiotropic Modulation of the Excitable Tissue.
Int. J. Mol. Sci. 23 (2), 917, (article identifier: 917), 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
20.
Horváth, B., Szentandrássy, N., Dienes, C., Kovács, Z. M., Nánási, P. P., Chen-Izu, Y., Izu, L. T., Bányász, T.: Exploring the Coordination of Cardiac Ion Channels With Action Potential Clamp Technique.
Front. Physiol. 13, 864002, (article identifier: 864002), 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Physiology
Q1 Physiology (medical)
21.
Horváth, B., Szentandrássy, N., Almássy, J., Dienes, C., Kovács, Z. M., Nánási, P. P., Bányász, T.: Late Sodium Current of the Heart: where Do We Stand and Where Are We Going?.
Pharmaceuticals (Basel). 15 (2), 231, (article identifier: 231), 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
22.
Kovács, Z. M., Dienes, C., Hézső, T., Almássy, J., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Szentandrássy, N.: Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 1: modulation of TRPM4.
Pharmaceuticals (Basel). 15 (1), 81, (article identifier: 81), 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
23.
Dienes, C., Kovács, Z. M., Hézső, T., Almássy, J., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Szentandrássy, N.: Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 2: TRPM4 in Health and Disease.
Pharmaceuticals (Basel). 15 (1), 40, (article identifier: 40), 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
24.
Horváth, B., Kiss, D. Z., Hézső, T., Veress, R., Dienes, C., Kovács, Z. M., Szentandrássy, N., Magyar, J., Bányász, T., Nánási, P. P.: Role of protein kinase A and calcium/calmodulin-dependent protein kinase II in beta-adrenergic regulation of potassium channels.
Acta Physiol. 236 (S725), 103-105, 2022.
DEA WoS
25.
Horváth, B., Kiss, D. Z., Veress, R., Kovács, Z. M., Dienes, C., Szentandrássy, N., Bányász, T., Magyar, J., Nánási, P. P.: Role of protein kinase A and calcium/calmodulin-dependent protein kinase II in beta-adrenergic regulation of potassium channels in canine ventricular cardiomyocytes.
J. Mol. Cell. Cardiol. 173 (Supplement), S148, 2022.
doi DEA WoS
DEENK University of Debrecen
© 2012 University of Debrecen
We use cookies on this site to enhance your user experience. By continuing to use the site, you agree to the use of cookies.